CVS Corp. sweetened its bid for Caremark Rx Inc. on Tuesday by tripling a proposed special cash dividend for the prescription drug benefit manager’s stockholders to $6 per share, after proxy advisory firms urged rejection of the previous offer.
*For more on this story,
read the full Reuters article.
